MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹155 Cr | ₹123 Cr | ₹98 Cr | ₹80 Cr | ₹72 Cr |
What is the latest Long Term Provisions ratio of MANKIND PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹155 Cr |
| Mar2024 | ₹123 Cr |
| Mar2023 | ₹98 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹72 Cr |
How is Long Term Provisions of MANKIND PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹155 Cr | 25.94 | |
| Mar2024 | ₹123 Cr | 25.78 | |
| Mar2023 | ₹98 Cr | 22.36 | |
| Mar2022 | ₹80 Cr | 10.74 | |
| Mar2021 | ₹72 Cr | - | |
Compare Long Term Provisions of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹82,454.7 Cr | -1.1% | -11.1% | -16.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -1.1% |
-11.1% |
-16.9% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses